Surgeons preparing a lung transplant in an operating room

Lung Perfusion and Assessment

TorEx

TorEx Lung Perfusion System with
TorEx Lung Perfusate

The TorEx Lung Perfusion System enables assessment of marginal donor lungs, supporting improved decision-making.

TorEx Lung Perfusion System for lung assessment and transplantation

Purpose-Built for the Toronto Technique

The only EVLP system designed for the Toronto Technique, the EVLP strategy that has resulted in the most lung transplants in the world1

Higher Donor Lung Volumes

The Toronto Technique allows more lungs to be transplanted2

Positive Impact on Waitlist Time and Mortality

Toronto General Hospital’s experience demonstrated significantly reduced waitlist time and mortality3

Improved Health Economic Outcomes

Higher transplant volumes have been demonstrated to lead to cost savings through reduced waitlist time, reduced time in intensive care, and better long-term outcomes3,4

Why TorEx?

The only EVLP system that enables the Toronto Technique, the EVLP strategy that has resulted in the most lung transplants in the world

Positive Left Atrial Pressure

Acellular Perfusate

Low Flow

Protective Volume-Controlled Ventilation

Gradual Rewarming

Rapid Cooling of Organ

The TorEx Lung Perfusion System enables comprehensive lung assessments through simple, straightforward device operation

Optimized user experience

Quick setup with simple “plug-and-play” chamber

Thoughtfully designed for user operation by fewer personnel

TorEx Lung Perfusion System

Allows a multifaceted assessment of lung function

Lung assessment images during perfusion process

Compact design reduces overall footprint

Mobility to accommodate changing needs in the OR

TorEx Lung Perfusate Solution

TorEx Lung Perfusate (TLP) is a cGMP-manufactured, sterile solution for ex vivo lung perfusion. Used to evaluate donor lung function prior to transplantation, TLP supports fluid balance and metabolic activity at 37°C during normothermic lung assessment procedures.

Contact Traferox to learn about TorEx indications and regulatory status in your country

Contact Us

This device is restricted to sale by or on the order of a licensed health care practitioner. Please refer to the instructions for use and indications for use in your country. This device is not currently approved for use or sale in the United States. Contact Traferox for more information.

  1. https://www.uhn.ca/corporate/News/Pages/1000th-Ex-Vivo-Lung-Perfusion-transplantation-surgery-celebrated-UHN.aspx ↩︎
  2. Divithotawela, C., Cypel, M., Martinu, T., Singer, L.G., Binnie, M., Chow, C.W., Chaparro, C., Waddell, T.K., de Perrot, M., Pierre, A. and Yasufuku, K., 2019. Long-term outcomes of lung transplant with ex vivo lung perfusion. JAMA surgery, 154(12), pp.1143-1150. ↩︎
  3. Peel, J.K., Pullenayegum, E.M., Naimark, D., Aversa, M., Liu, M., Del Sorbo, L., Barrett, K., Sander, B. and Keshavjee, S., 2023. Evaluating the impact of ex vivo lung perfusion on organ transplantation: a retrospective cohort study. Annals of Surgery, 278(2), pp.288-296. ↩︎
  4. Peel, J.K., Keshavjee, S., Naimark, D., Liu, M., Del Sorbo, L., Cypel, M., Barrett, K., Pullenayegum, E.M. and Sander, B., 2023. Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: a retrospective cohort study. The Journal of Heart and Lung Transplantation, 42(3), pp.356-367. ↩︎